Evidence-based medicine, it seems commonsensical; who could argue about using the best evidence available to make treatment decisions? The difficulty, of course, is that the evidence comes from studies of large populations, often expressed in terms of average responses; and as a clinician, you want to tailor the care to the one member of the population in front of you, your patient. Continue reading →

PHILADELPHIA There's sunny news, potentially, for patients with heart failure who are keen on cannabis. Hospitalized patients with a primary diagnosis of acute heart failure (HF) who say they are marijuana users are more likely to survive to discharge than nonusers, and they stay fewer days at less cost to the hospital, an observational study suggests Continue reading →

Top-line results projected to be available on or about September 30, 2019 Number of MACE increases from 250 to greater than 275 CALGARY, Alberta, Sept. Continue reading →

September has been a relatively slow month for the U.S. Food and Drug Administration (FDA) Continue reading →

Ventricular tachycardia is a life threatening heart condition in which arrhythmic heart beats occur in the ventricles. The two lower chambers of the heart are known as ventricles Continue reading →

Although guidelines permit up to a 30% acute increase in creatinine following initiation of renin angiotensin system inhibitors (RASi), new evidence published in the Clinical Journal of the American Society of Nephrology associates creatinine rises of 10% or more with increased risks for death, cardiovascular events, and end-stage renal disease (ESRD). Continue reading →